the shot is singular. Was it J and J? prior to shutdown.
My bet. It is a cross ref for person getting the shot. Peel off, give shot, scan code , attach data file to patient.
wrong
'How can a democracy function if we can't talk to one another?' U.S. justices…
The race for a successful coronavirus vaccine is heating up in labs around the world — and on Wall Street. Germany's CureVac, a biotech with the backing of the Bill & Melinda Gates Foundation, more than tripled in its first day of trading Friday.
Bill Gates, Melinda Gates are posing for a picture: Bill Gates and his wife Melinda Gates introduce the Goalkeepers event at the Lincoln Center on September 26, 2018, in New York. (Photo by Ludovic Marin/AFP/Getty Images)© Ludovic Marin/AFP/Getty Images Bill Gates and his wife Melinda Gates introduce the Goalkeepers event at the Lincoln Center on September 26, 2018, in New York. (Photo by Ludovic Marin/AFP/Getty Images)
CureVac priced its initial public offering at $16 a share. The stock soared nearly 250%, to just below $56, by the end of the day.
The company, which is competing with the likes of Moderna, Novavax, BioNTech and Pfizer, is also backed by billionaire Dietmar Hopp, the co-founder of German software giant SAP.
Hopp owns nearly half of CureVac. The German government and Big Pharma leader GlaxoSmithKline also have big stakes.
The Bill & Melinda Gates Foundation, the charitable arm of the multibillionaire Microsoft co-founder and his wife, invested $40 million in the company in 2015.
CureVac recently received approval from the governments of Germany and Belgium to start clinical trials for one of its vaccines for Covid-19.
The company generated €17.4 million ($20.6 million) in revenue in 2019, an increase of 35% from the prior year. It is not yet profitable.
CureVac also has another big name in its roster of partners: the firm is working on technology with Elon Musk's electric car giant Tesla. The company has had a development and intellectual property agreement with Tesla since November 2015, according to its regulatory filings with the Securities and Exchange Commission.
Musk tweeted last month that Tesla's German Grohmann division is helping build molecule printers for CureVac — a "side project" that may work with other drug companies.
CureVac is one of several biotechs that has attracted attention from the Trump administration as well. The company denied published reports earlier this year that President Trump was seeking to get some of the company's German scientists to come to the United States to work on a vaccine.
Hopp has not ruled out the possibility of the company working more closely with the US,
or b12 who the fuck knows.
You know she thinks she is really clever and is a dumb cunt.